Wikidata

(Q113888955)

English

Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
*Official Title: Randomized, Open-label, Single-dose, Two-sequence, Two-period, Crossover Bioequivalence Trial of Irinotecan Liposome Injection in Patients With Advanced Pancreatic Cancer. (English)
0 references
start time
7 July 2020
0 references
end time
December 2020
0 references
number of participants
48
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113888955&oldid=2149427398"